Baudax Bio Inc Sustainability Reports
Baudax Bio, Inc. is a pharmaceutical company that focuses on developing and commercializing products for hospital and acute care settings. Its pipeline includes T-cell receptor therapies for autoimmune disorders and neuromuscular blocking agents.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
FIGI: BBG00QS35Q48
1 reports from 2019 to 2019
Company Profile
Baudax Bio, Inc. is a pharmaceutical company that focuses on developing and commercializing products for hospital and acute care settings. Its pipeline includes T-cell receptor therapies for autoimmune disorders and neuromuscular blocking agents.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
